Please login to the form below

Not currently logged in
Email:
Password:

Excellence in Healthcare Professional Education and Support Programmes

Sponsored by

Back to Results


Winner

Angels Initiative

by Boehringer Ingelheim International GmbH


Summary of work

The Angels Initiative is a non-promotional, global healthcare initiative by Boehringer Ingelheim International GmbH endorsed by the World Stroke Organisation WSO, the European Stroke Organisation ESO, the European patient organisation SAFE and many other national stroke organisations to assist in implementing their main goal, to improve the stroke care across the world.

The mission of the Angels Initiative is simple: to increase the number of patients treated in stroke ready hospitals and to optimise the quality of treatment in all existing stroke centres.

The principal aim of the ANGELS initiative is to develop a community of ’stroke ready’ hospitals, and to encourage and improve acute stroke networks between hospitals in order to share information, set up stroke units, and improve treatment procedures and outcomes.

The core of the Angels Initiative are more than 140 Angels consultants in more than 40 countries that support stroke teams to scale-up acute stroke treatment, to optimise patient pathways, to improve and measure quality of the care. The Angels Initiative provides unique resources, training opportunities, and support for physicians and nurses that are provided in meetings and workshop or digital on the multilingual webpage www.angels-initiative.com

Judges' comments

The Angels Initiative had a major impact on saving lives. It had great awareness and training and did exceptionally well in terms of quality of execution with ambitious SMART objectives. It had outstanding stakeholder verdicts and the judges thought the European research was exceptional. It had clear objectives and strategy, was very ambitious and had a fantastic mix of initiatives.


Highly commended

CLEAR HORIZONS: A New Era of Psoriasis Care - by AbbVie with support from Lucid Group


Highly commended

Academy for Science and Continuing Medical Education in Diabetes (ASCEND) - by Novo Nordisk [unrestricted grant provider] with support from International Medical Press, a Nucleus Global agency


Finalists

INSPIRE: Improving Outcomes in Paediatric Cardiology - by AbbVie with support from Lucid Group

4 Sites: Navigating the Course Ahead - by AbbVie with support from Sciterion

Advanced Communication Training for Heart Failure Nurses - by Novartis with support from Aurora


Key dates

Entry deadline 29 August 2019
Extended entry deadline 5 September 2019*
*additional fee applies
Judging day 26 September 2019
Company/Team Interviews 9 October 2019
PMEA Event 27 November 2019